logo

Shariah compliance overview

Not Halal

Avalyn Pharma Inc. Common Stock (AVLN) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs).

Avalyn Pharma Inc. Common Stock (AVLN) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
0.00%Limit 30%Pass
Interest-bearing securities and assets
10.28%Limit 30%Pass
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Avalyn Pharma Inc. Common Stock (AVLN). Current Akinda screening label: Not Halal.